/UNBX
UNBX Stock - Unity Biotechnology, Inc.
Healthcare|BiotechnologyOTC
$0.06+0.00%
+$0.00 (+0.00%) • Oct 14
49
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.72
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.06
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for UNBX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.06 – $0.06
TARGET (TP)$0.06
STOP LOSS$0.05
RISK/REWARD1:0.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.19
52W High$3.10
52W Low$0.05
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
Unity Biotechnology, Inc. is a biotechnology firm developing therapies to slow, halt, or reverse aging-related diseases with programs like senolytic candidates targeting ophthalmologic and neurologic disorders.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
UNBXBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$N/A
EPS Surprise History
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 30, 2025 | $-0.30 | — | — | — |
Q3 2025 | Aug 26, 2025 | $-0.30 | — | — | — |
Latest News
Loading news...
Frequently Asked Questions about UNBX
What is UNBX's current stock price?
Unity Biotechnology, Inc. (UNBX) is currently trading at $0.06 per share. The stock has moved +0.00% today.
What is the analyst price target for UNBX?
No analyst price targets are currently available for this stock.
What sector is Unity Biotechnology, Inc. in?
Unity Biotechnology, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is UNBX's market cap?
Unity Biotechnology, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does UNBX pay dividends?
No, Unity Biotechnology, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBIOR
Biora Therapeutics, Inc.
$0.22
Mkt Cap: $0.0B
CAIHF
Chia Tai Enterprises International Limited
$0.28
Mkt Cap: $0.2B
EPGNF
Epigenomics AG
$1.12
Mkt Cap: $0.0B
EVFM
Evofem Biosciences, Inc.
$0.01
Mkt Cap: $0.0B
HALB
Halberd Corporation
$0.00
Mkt Cap: $0.0B
MRZM
Marizyme, Inc.
$0.00
Mkt Cap: $0.0B
NTRR
Neutra Corp.
$0.00
Mkt Cap: $0.0B
ORGS
Orgenesis Inc.
$0.75
Mkt Cap: $0.0B
SQZB
SQZ Biotechnologies Company
$0.02
Mkt Cap: $0.0B
TBIO
Telesis Bio, Inc.
$0.11
Mkt Cap: $0.0B
Explore stocks similar to UNBX for comparison